Predicting drug response of small cell lung cancer cell lines based on enrichment analysis of complex gene signatures

J Biotechnol. 2024 Mar 10:383:86-93. doi: 10.1016/j.jbiotec.2024.01.010. Epub 2024 Jan 26.

Abstract

Advances in the field of genomics and transcriptomics have enabled researchers to identify gene signatures related to development and treatment of Small Cell Lung Cancer. In most cases, complex gene expression patterns are identified, comprising of genes with differential behavior. Most tools use single-genes as predictors of drug response, with only limited options for multi-gene use. Here we examine the potential of predicting drug response using these complex gene expression signatures by employing clustering and signal enrichment in Small Cell Lung Cancer. Our results demonstrate clustering genes from complex expression patterns helps identify differential activity of gene groups with alternate function which can then be used to predict drug response.

Keywords: Drug response; Gene expression; Immune; SCLC; Signature; SsGSEA.

MeSH terms

  • Cell Line
  • Gene Expression Profiling
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Lung Neoplasms* / metabolism
  • Small Cell Lung Carcinoma* / drug therapy
  • Small Cell Lung Carcinoma* / genetics
  • Small Cell Lung Carcinoma* / metabolism
  • Transcriptome / genetics